0 items
Your cart is empty.
99.2% On-Time Delivery
Tracked International Shipping
Refund Within 28 Days
Secure, Encrypted Checkout
Each peptide batch is tested and verified to meet or exceed 98–99% purity (HPLC).
Store 2–8 °C (≤–20 °C long-term). RT exposure during transport acceptable. Protect from light.
99.2% On-Time Delivery
Tracked International Shipping
Refund Within 28 Days
Secure, Encrypted Checkout
$175.00
This product is available by prescription only
This product does not require a prescription
Each peptide batch is tested and verified to meet or exceed 98–99% purity (HPLC).
Store 2–8 °C (≤–20 °C long-term). RT exposure during transport acceptable. Protect from light.
The product is delivered in powdered (lyophilized) form and must be properly reconstituted prior to research use.
Retatrutide 20mg is supplied as a lyophilized powder. This means the compound has been freeze-dried to improve shelf stability and long-term storage integrity. The retatrutide lyophilized format allows laboratories to reconstitute precise concentrations for controlled research design. High concentration reduces the need for multiple vials in extended protocols.
This peptide interacts with three receptor pathways in laboratory models. These receptors are commonly studied in metabolic signaling research. Each batch is produced by ELIVENA in USA GMP facilities. GMP stands for Good Manufacturing Practice. This ensures controlled production standards. Every product includes a Certificate of Analysis confirming purity above 99%. These products are classified strictly as research chemicals and not approved as a drug or food substance.
In laboratory settings, retatrutide is examined for its interaction with GIP, GLP-1, and glucagon receptors. These receptors are involved in energy balance and nutrient signaling. GIP relates to glucose-dependent insulin signaling. GLP-1 supports glucose regulation pathways. Glucagon receptors are linked to energy release processes. Researchers analyze how coordinated receptor activity may influence measurable metabolic markers under controlled conditions.
Retatrutide 20mg is provided for laboratory research only. It is not intended for human consumption or veterinary application. It must not be introduced into humans or animals. This product is not a drug and not a food product. It is categorized among controlled research chemicals for scientific purposes.
Before use, store the lyophilized powder at 2–8°C. Protect from light and moisture. Reconstitution should be performed using sterile laboratory-grade solvent under controlled research conditions. Laboratories determine concentration levels based on study design. Handling must follow institutional safety procedures.
This product is manufactured by ELIVENA in GMP-certified USA facilities. Each batch is tested for purity, identity, and stability. Researchers working with peptides bulk quantities or structured peptide investigations benefit from consistent formulation. Purchasing should be conducted by qualified institutions only. Always review local regulations before purchasing research peptides.
Retatrutide 20mg is designed for qualified laboratories conducting structured metabolic and receptor pathway research. This product supports scientific teams studying energy signaling, nutrient processing, and multi-receptor interaction models under controlled experimental conditions. It is suitable for institutions investigating how peptide-based compounds influence cellular communication linked to metabolism and longevity markers.
Researchers working with research chemicals and structured endocrine models often require consistent, high-concentration materials. This vial format supports extended protocols while maintaining stability and reproducibility. It is supplied strictly for research purposes only. It is not intended for human consumption, not a drug, and not a food ingredient. It must not be used in medical conditions or alongside medications. All purchasing must comply with institutional laboratory standards.
Novera Research delivers high-quality research peptides developed under strict manufacturing and quality-control standards. Each product is carefully synthesized, tested, and handled to ensure consistency, reliability, and transparency for advanced research applications.
High-purity, research-grade peptide synthesis
Analytical testing to verify quality and composition
Consistent batch-to-batch performance
Batch identification on every vial for traceability
Stored and shipped under controlled conditions
Research-grade synthetic dual-peptide formulation combining amylin analog and GLP-1 receptor agonist for dual-mechanism pathway studies and combination peptide research in controlled laboratory environments.
Research-grade dual GIP/GLP-1 peptide by NOVERA, USA-made, 99% purity, for advanced metabolic studies.
Research-grade synthetic dual-agonist peptide formulated in 10mg quantity for dual-receptor mechanism studies and peptide-receptor interaction research in controlled laboratory environments.
A synthetic 44-amino acid analog of growth hormone-releasing hormone studied for pituitary receptor binding kinetics, GHRH pathway signaling dynamics, and downstream somatotropic axis marker activity in controlled preclinical models.
Explore GHK-CU BPC-157 Tb-500 KPV Klow Blend, Novera's most advanced peptide blend. This superior four-peptide formula delivers unmatched benefits for skin and tissue repair, inflammatory balance, and rapid recovery.
